Concepedia
Statistics
Publications
19
Citations
671
H-Index
15
Active since
1992
Affiliations
Merck Canada Inc. (Canada)(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Université de Montréal
TransCanada (Canada)
United States Military Academy
Christophe Mellon is an author at Merck Canada Inc. (Canada) specializing in medicinal chemistry, drug discovery, and pharmacology.
Publications per year
1992–2013
Difluoroethylamines as an amide isostere in inhibitors of cathepsin K
Élise Isabel, Christophe Mellon, Michael J. Boyd et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 111 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +12
Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Disease Cure
Momar Ndao, Christian Beaulieu, W. Cameron Black et al. · Antimicrobial Agents and Chemotherapy · 2013 · 103 citations · Full text
Medicine, Infectious Diseases, Pharmacology +16
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease
Christian Beaulieu, Élise Isabel, Angélique Fortier et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 70 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +5
An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells
Jean‐Pierre Falgueyret, W. Cameron Black, Wanda Cromlish et al. · Analytical Biochemistry · 2004 · 52 citations
Life Sciences, Biochemistry, Molecular Biology +16
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases
Michel Gallant, Christian Beaulieu, Carl Berthelette et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 49 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +10
1–5 of 19